This is a unique opportunity to hear about Leighton’s four decades of experience working in Silicon Valley biotech investing.
Leighton’s impressive career includes roles as Managing Director at Interhealth Partners and Alloy Ventures, and founding key companies such as Affymax NV, Aviron, and Avidia. Currently, he is the Non-Executive Chairman of Global Kinetics and a director at Allay Therapeutics and Glyscend Therapeutics.
Details:
20 August 2024, 5:00 pm-7:30 pm ACST
RSM Australia, Level 32 Exchange Tower (2 The Esplanade, Perth)
Plus networking after the event!